Table 2 Overall survival for the 2006–2009, 2010–2013, 2014–2018 period of follow-up for patients with multiple myeloma in Armenia (1- and 5-year estimates with 95% confidence level)
From: Multiple myeloma in Armenia during the period 2006–2018: facts and discussion
1-year survival rates | 5-year survival rates | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Male | Female | Total | Male | Female | ||||||||
≤60 | > 60 | ≤60 | > 60 | ≤60 | > 60 | ≤60 | > 60 | ≤60 | > 60 | ≤60 | > 60 | ||
2006–2009 | % | 83 | 78.5* | 87.5 | 95* | 80 | 72.2* | 21.3 | 17 | 17.6 | 11.1* | 25 | 22.9* |
CI | 73.2–92.8 | 66.6–76.5 | 74.3–100 | 84.9–100 | 66.1–93.9 | 55.6–88.8 | 10.6–32 | 6.1–27.9 | 2.4–32.8 | 0–25.6 | 10–40 | 7.3–38.5 | |
n | 56 | 46 | 24 | 18 | 32 | 28 | 56 | 46 | 24 | 18 | 32 | 28 | |
2010–2013 | % | 85.5 | 82.1 | 75.8 | 87.6* | 87.5 | 84.2 | 18.5 | 17.6* | 13.6 | 13.1 | 23.4 | 22.2* |
CI | 78.5–92.5 | 76.6–91.6 | 63.8–87.8 | 76.7–98.5 | 78.2–96.8 | 70.4–98 | 10.8–26.2 | 8.1–27.1 | 4–23.2 | 1.9–24.3 | 11.5–35.3 | 6.5–37.9 | |
n | 98 | 62 | 49 | 35 | 49 | 27 | 98 | 62 | 49 | 35 | 49 | 27 | |
2014–2018 | % | 64.1 | 68.1 | 48.9 | 66.9* | 73.8 | 72 | – | – | – | – | – | – |
CI | 54.9–73.3 | 59.7–76.5 | 35.4–62.4 | 54.6–79.2 | 61.7–85.9 | 60.7–83.3 | |||||||
n | 104 | 117 | 53 | 56 | 51 | 61 | |||||||